Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 November 2006

Leptin increases proliferation of human osteosarcoma cells through activation of PI(3)-K and MAPK pathways

Bartolome Burguera, Amy Brunetto, Adolfo Garcia-Ocana, Roseta Teijeiro, James Esplen, Thierry Thomas, Marta E. Couce, Allan Zhao

Med Sci Monit 2006; 12(11): BR341-349 :: ID: 462552

Abstract

Background: Serum leptin levels are strongly and directly related to fat body mass (FBM). Bone mineral density(BMD) increases with FBM, and obesity has a protective effect against osteoporosis. We have previously demonstrated that leptin therapy has a signifi cant effect in preventing ovariectomy-induced
bone loss in rats and leptin also exerts direct osteogenic effects in vitro. To obtain a better understanding of the physiology and pharmacology of leptin in bone metabolism, we evaluated the leptin-induced signal transduction pathways and proliferative response in the human osteosarcoma cell line Saos-2.
Material/Methods: Saos-2 cell lines were used. Leptin receptor common form (OB-Ra) and long form (OB-Rb) were detected by RT-PCR and immunocytochemistry. PI(3)-K activity was immunoprecipitated using antibodies
directed against tyrosine-phosphorylated proteins and IRS-1. The activated form of p42/p44 MAPK was investigated in cytosolic extracts of confl uent Saos-2 in response to leptin.
Results: In this study, we tested the hypothesis that leptin might be a mediator linking obesity and bone
cell proliferation. We found that Saos-2 cells expressed OB-Ra and OB-Rb. Leptin (10 nmol/L –
2 umol/L) caused a signifi cant increase in the activation of PI(3)-K that was accompanied by an
increase in cell proliferation dose dependently based on the [[sup]3[/sup]H]-thymidine incorporation. The
specifi c PI(3)-K inhibitors LY294002 and wortmannin blocked leptin-induced cell proliferation.
Interestingly, leptin activated MAPK and the specifi c MAPK-inhibitor PD98059 blocked DNA synthesis
induced by leptin.
Conclusions: Our data support the hypothesis that leptin may increase bone mass by stimulating osteoblast proliferation through activation of the PI(3)-K and MAPK signaling pathways.

Keywords: Bone and Bones - metabolism, Enzyme Inhibitors - pharmacology, Insulin Receptor Substrate Proteins, Leptin - physiology, Osteosarcoma - pathology, Phosphatidylinositol 3-Kinases - metabolism, Phosphoproteins - metabolism, Phosphorylation, Tyrosine - chemistry

Add Comment 0 Comments

Editorial

01 March 2025 : Editorial  

Editorial: The World Health Organization (WHO) Updated List of Emerging and Potentially Pandemic Pathogens Includes Yersinia pestis as Plague Vaccines Await Clinical Trials

Dinah V. Parums

DOI: 10.12659/MSM.948672

Med Sci Monit 2025; 31:e948672

0:00

In Press

Clinical Research  

Evaluation of Attitudes to Learning Doctor-Patient Communication Skills in 427 Postgraduate Doctors Using t...

Med Sci Monit In Press; DOI: 10.12659/MSM.947276  

0:00

Clinical Research  

Exploring the Association Between Serum Neurogranin, Nardilysin, and Ischemic Stroke: A Case-Control Study ...

Med Sci Monit In Press; DOI: 10.12659/MSM.947703  

0:00

Clinical Research  

Comparative Analysis of Laser Therapies for Striae Distensae: Fractional COâ‚‚ vs Combined Q-Switch Nd:YAG

Med Sci Monit In Press; DOI: 10.12659/MSM.947464  

Database Analysis  

Utility of Central Venous Oxygen Saturation Gradient in Predicting Mortality in Dialysis with Catheter Access

Med Sci Monit In Press; DOI: 10.12659/MSM.947298  

Most Viewed Current Articles

17 Jan 2024 : Review article   7,082,464

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research   702,311

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Mar 2024 : Editorial   27,546

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...

DOI :10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

28 Jan 2024 : Review article   21,733

A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future

DOI :10.12659/MSM.943912

Med Sci Monit 2024; 30:e943912

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750